Polymedco Announces: New Published Research Supports Fecal Immunochemical Testing (FIT) as the Most Clinically and Cost Effective Noninvasive Colorectal Cancer Screening (CRC) method February 20, 2025
Polymedco announces US FDA clearance of the PATHFAST high-sensitivity cardiac troponin I (hs-cTnI-II) test as an aid in the diagnosis of myocardial infarction March 27, 2024
